Asia Pacific COPD and Asthma Devices Market to reach $15,893.9 Million by 2022, growing at a CAGR of 6.5% during 2016-2022

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

The Asia Pacific COPD and Asthma Devices Market attained a market size of $ 10,267.8  Million in 2015 and is expected to reach $ 15,893.9  Million by 2022 growing at a CAGR of  6.5 % CAGR during 2016 - 2022. The Metered Dose Inhalers (MDIs)  market dominated the Asia Pacific COPD and Asthma Inhaler Market  in 2015 and would continue till 2022, growing at a CAGR of  5.4 % during the forecast period. The Soft Mist Inhalers (SMIs) market is expected to reach a market size of $4,339.9 Million by 2022. The Dry Powder Inhalers (DPIs) market would witness the high growth rate of  8.7  % during 2016-2022.

The  China  market is expected to continue its dominance thereby growing at a CAGR of  7.0 % during the forecast period. The Japan market is expected to reach a market size of $  1,796.0  Million by 2022. The India market would witness the high growth rate of  8.5  % during 2016-2022. The report highlights the adoption of COPD & Asthma Devices in the Asia Pacific. Based on the product type; the market is segmented into Inhalers and Nebulizers market.

Further, the Inhaler segment is sub-segmented into Dry Powder Inhalers, Metered Dose Inhalers and Soft Mist Inhalers Market. The Nebulizers segment is bifurcated into Pneumatic Nebulizers, Ultrasonic Nebulizers, and Mesh Nebulizers Market. The countries included in the report are Germany, UK, France, Russia, Spain, Italy and Rest of Asia Pacific. Key players profiled in the report include Glaxosmithcline PLC., Novartis International AG., Biotronik SE & Co. KG., AstraZeneca Plc., 3M Healthcare, GF Health Products, Inc., Sunovion Pharmaceuticals Inc., Smith Medicals, Inc., Baxter International and Philips.

Full report: https://www.kbvresearch.com/asia-pacific-copd-and-asthma-devices-market/

Research Scope

The market is segmented based on product type and country.

Asia Pacific COPD and Asthma Devices Market, By Product Type

  • Asia Pacific COPD and Asthma Devices Market
    • Asia Pacific COPD and Asthma Inhaler Market
      • Asia Pacific COPD and Asthma Dry Powder Inhalers (DPIs) Market
      • Asia Pacific COPD and Asthma Metered Dose Inhalers (MDIs) Market
      • Asia Pacific COPD and Asthma Soft Mist Inhalers (SMIs) Market
    • Asia Pacific COPD and Asthma Nebulizer Market
      • Asia Pacific COPD and Asthma Pneumatic Nebulizers Market
      • Asia Pacific COPD and Asthma Ultrasonic Nebulizer Market
      • Asia Pacific COPD and Asthma Mesh Nebulizer Market

Asia Pacific COPD and Asthma Devices Market, By Country

  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Malaysia
    • Rest of Asia Pacific

Related Reports:

Global COPD and Asthma Devices Market

North America COPD and Asthma Devices Market

Europe COPD and Asthma Devices Market

LAMEA COPD and Asthma Devices Market

Request For Sample


Why Choose Us

  • 24/7 Research support
    Get your queries resolved from an industry expert. Request for a free product review before report purchase.

  • Information security
    Your personal and confidential information is safe and secure.